{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:53:07Z","timestamp":1670374387599},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.cancergencyto.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,12,20]],"date-time":"2008-12-20T10:32:58Z","timestamp":1229769178000},"page":"112-117","source":"Crossref","is-referenced-by-count":2,"title":["ETV6\/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"188","author":[{"given":"Paulo R.G.","family":"Zen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo E.Z.","family":"Capra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia M.R.","family":"Silla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiseh F.","family":"Loss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidia M.C.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio A.","family":"Paskulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/asheducation-2003.1.102","article-title":"Pediatric acute lymphoblastic leukemia","author":"Carroll","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1517\/14656566.8.15.2519","article-title":"Pharmacogenetics of acute lymphoblastic leukemia treatment response","volume":"8","author":"Cunningham","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35106108","article-title":"Chromosome translocations: dangerous liaisons revisited","volume":"1","author":"Rowley","year":"2001","journal-title":"Nat Rev"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib5","first-page":"508","article-title":"Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia","volume":"118\u201322","author":"Downing","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","article-title":"High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia","volume":"86","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/gcc.20423","volume":"46","author":"Forestier","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","volume":"90","author":"Borkhardt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(00)00272-7","article-title":"TEL\/AML-1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia","volume":"122","author":"Jamil","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/10428190109097675","article-title":"Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia","volume":"42","author":"Uckun","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2005-08-3451","article-title":"Prospective analysis of TEL\/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01","volume":"107","author":"Loh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib12","doi-asserted-by":"crossref","unstructured":"Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B, Richards S; UK Medical Research Council's Working Party on Childhood Leukaemia. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001;113:103\u201314.","DOI":"10.1046\/j.1365-2141.2001.02668.x"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2141.2001.02673.x","article-title":"TEL\/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia","volume":"113","author":"Hubeek","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Total Therapy Study XIIIB at St Jude Children's Research Hospital. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cancergencyto.2003.09.003","article-title":"Prevalence of TEL\/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia","volume":"151","author":"Zen","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/sj.leu.2401977","article-title":"Long-term results of large prospective trials in childhood acute lymphoblastic leukemia","volume":"14","author":"Schrappe","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib17","first-page":"142","article-title":"Brazilian Group. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85","volume":"2","author":"Brandalise","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.leu.2404640","article-title":"Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia","volume":"21","author":"Martin","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.005_bib20","unstructured":"Scrideli CA, Andrade VSS, Yunes JA, Brandalise SR, Toledo SRC, Lee MLM, Petrilli AS, Bendit I, Odone-Filho V, Tone LG. Expression profile analysis of genes related to resistance\/sensibility to prednisolone, daunorubicin, asparaginase and vincristine in childhood acute lymphoblastic leukemia (PA.017). Supplement: 39th Annual Conference of the International Society of Paediatric Oncology SIOP 2007, Mumbai, India, 31 October\u20133 November 2007, SIOP Abstracts. Pediatr Blood Cancer 2007;49:443\u20134 [Abstract]."}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808005372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808005372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:30:53Z","timestamp":1589416253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460808005372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0165460808005372"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.09.005","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}